CLPTM1L Antikörper
-
- Target Alle CLPTM1L Antikörper anzeigen
- CLPTM1L (CLPTM1-Like (CLPTM1L))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CLPTM1L Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human CLPTM1L
- Isotyp
- IgG
- Top Product
- Discover our top product CLPTM1L Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.7 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Handhabung
- Avoid freeze / thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CLPTM1L (CLPTM1-Like (CLPTM1L))
- Andere Bezeichnung
- CLPTM1L (CLPTM1L Produkte)
- Synonyme
- CRR9 antikoerper, C130052I12Rik antikoerper, Crr9 antikoerper, RGD1307896 antikoerper, C130052I12RIK antikoerper, CLPTM1 like antikoerper, CLPTM1-like antikoerper, cleft lip and palate transmembrane protein 1-like protein antikoerper, CLPTM1L antikoerper, clptm1l antikoerper, LOC100338302 antikoerper, Clptm1l antikoerper
- Hintergrund
- Cleft lip and palate transmembrane protein 1-like protein(CLPTM1-like protein), also known ascisplatin resistance-related protein 9(CRR9p), is aproteinthat in humans is encoded by theCLPTM1Lgene.CRR9p is associated withcisplatin-inducedapoptosis.CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.
- NCBI Accession
- NP_110409
-